LAB-QM-003 — Continual Improvement, Quality Indicators, and Performance Improvement Program Policy

1.0 Purpose

To establish a unified Continual Improvement, Quality Indicators, and Performance Improvement Program for the Tarangnan Community Hospital (TCH) Clinical Laboratory.

This policy defines how the laboratory selects, defines, monitors, and evaluates quality indicators across pre-examination, examination, and post-examination processes, and how improvement opportunities are prioritized based on risk, implemented through the Continual Quality Improvement (CQI) Committee, and sustained to improve patient care outcomes.

2.0 Scope

This policy applies to all Medical Technologists and Laboratory Aides across all sections of the TCH Clinical Laboratory, as well as members of the laboratory CQI Committee. It covers quality indicator monitoring and continual improvement across governance, pre-examination, examination, post-examination, point-of-care testing (POCT), personnel competence, equipment and reagent management, information management, customer satisfaction, workload/test volume, and biosafety.

Detailed operational procedures for related QMS processes are governed by their respective policies and are not duplicated here:

• Risk assessment — Risk Management
• Nonconformities and occurrences — Occurrence Management Policy
• Corrective and preventive action (CAPA) — Corrective and Preventive Action Policy
• Internal audit and Management Review — Internal Audit and Management Review

3.0 Definitions

• Continual Improvement — recurring activity to enhance the effectiveness of the laboratory management system and its pre-examination, examination, and post-examination processes.
• Quality Indicator (QI) — an objective, measurable variable used to monitor and evaluate the performance of a defined laboratory process or outcome over time against a quality objective.
• Target / Threshold — the pre-defined acceptable performance level or limit against which actual indicator results are compared and interpreted.
• Methodology — the documented procedure for measuring an indicator, including data source, numerator, denominator, calculation formula, and unit of measure.
• Action Plan — the pre-defined response triggered when an indicator fails to meet its target or exceeds its threshold, proportionate to patient-safety risk.
• Risk-Based Prioritization — directing improvement efforts toward processes with the highest potential impact on examination accuracy and patient or staff safety.

4.0 Responsibility

4.1 Hospital Director

• Approves this policy, designates the CQI Committee in writing, and provides institutional resources required for quality improvement initiatives.
• Reviews laboratory indicator performance and approves strategic improvement priorities during Management Review.

4.2 Pathologist

• Chairs the CQI Committee and reviews selected quality indicators, targets, and improvement projects for clinical relevance and patient-safety impact.
• Participates in Management Review of continual improvement and quality indicator outcomes.

4.3 Chief Medical Technologist / Laboratory Quality Manager

• Serves as Secretary of the CQI Committee and manages the day-to-day Quality Indicator and Continual Improvement Program end-to-end (indicator planning, data verification, trending, reporting, and follow-up).
• Maintains the Quality Indicator Register, CQI Schedule, and Performance Improvement Log (F-QM-003-A-V0) and CQI Project Charter and Committee Minutes (F-QM-003-B-V0).
• Extracts laboratory-relevant entries from the hospital-wide Client Feedback Form and staff/user feedback, communicates improvement goals and actions taken to personnel, and presents CQI reports at Management Review.

4.4 Medical Technologists

• Collect, record, and verify assigned quality indicator data at defined intervals using approved logs and the TCH LIS.
• Report process weaknesses, indicator deviations, and improvement suggestions, and participate in implementing and evaluating assigned CQI projects.
• Provide one Medical Technologist representative to serve on the CQI Committee.

4.5 Laboratory Aides

• Record assigned non-technical support logs (such as temperature, cleaning, and waste logs) accurately and on time to support indicator tracking.
• Report observed support-process issues to the Medical Technologist or Chief Medical Technologist / Laboratory Quality Manager and cooperate with workplace improvements.
• Do not perform, verify, authorize, interpret, or release technical examinations or results.

4.6 Nursing / Ward Representative (Applicable Personnel)

• Serves as a member of the laboratory CQI Committee to provide clinical ward and end-user feedback on specimen collection, turnaround time, and result communication.

5.0 Policy / Procedure

5.1 Policy Statement, Quality Improvement Plan, and Quality Objectives

The Clinical Laboratory shall continually improve the effectiveness of its Quality Management System, including pre-examination, examination, and post-examination processes, in alignment with the quality objectives defined in Quality Management Manual.

The laboratory shall establish, plan, and periodically review measurable Quality Indicators to monitor performance against quality objectives, identify opportunities for improvement, direct improvement actions at areas of highest risk to patient care, and evaluate the effectiveness of actions taken (see Figure 1).

Laboratory management shall ensure active participation in continual improvement activities that encompass relevant areas and outcomes of patient care and shall communicate improvement plans and goals to all personnel.

Figure 1 — PDCA quality indicator monitoring and CQI project lifecycle

5.2 CQI Committee and Annual Study Schedule

• Designation and Composition: The Hospital Director shall designate in writing a Continual Quality Improvement (CQI) Committee composed of: - Chair: Pathologist - Secretary: Chief Medical Technologist / Laboratory Quality Manager - Members: One (1) Medical Technologist representative and one (1) Nursing/Ward representative
• Operational Structure: Because TCH operates with a lean six-person laboratory staff, the Chief Medical Technologist / Laboratory Quality Manager executes day-to-day indicator tracking and coordinates CQI activities under the oversight of the CQI Committee.
• Meetings and Annual Schedule: The CQI Committee shall meet at least quarterly to review quality indicator trends, approve CQI project charters before implementation, and update the annual CQI study schedule (F-QM-003-A-V0). Committee minutes and project charters shall be recorded on F-QM-003-B-V0 and reported to Management Review per Management Review.

5.3 Selection, Planning, and Specification of Quality Indicators

• Selection Criteria and Coverage: Quality indicators shall be objective, quantifiable, and risk-based, covering key pre-examination, examination, post-examination, and support processes (including turnaround time, specimen acceptability, IQC/EQAS performance, critical-value notification, corrected reports, customer satisfaction, and test workload). Before implementing an indicator, the laboratory shall confirm that a reliable data source and measurement methodology exist and shall account for any known limitations of the data source.
• Required Planning Elements: Every approved quality indicator shall be documented in F-QM-003-A-V0 prior to implementation with the following specification fields:

• Core TCH Quality Indicators: At minimum, the laboratory tracks the following core indicators in F-QM-003-A-V0: - Pre-Examination: Specimen rejection rate; patient/specimen identification error rate. - Examination: Internal QC (IQC) acceptance rate; NEQAS/EQAS proficiency testing pass rate; equipment downtime. - Post-Examination & Support: STAT and routine Turnaround Time (TAT) compliance; critical-value notification compliance (within 15 minutes with read-back); corrected/amended report rate; client satisfaction and complaint rate; monthly test volume and workload.

5.4 Data Collection, Analysis, Trending, and Out-of-Target Action

• Standardized Data Collection: Medical Technologists and Laboratory Aides shall record indicator data at the time of the activity using the TCH Excel LIS or approved bench logs. For customer service and satisfaction indicators, the laboratory shall use TCH's existing hospital-wide Client Feedback Form alongside F-QM-004-A-V0; the Chief Medical Technologist / Laboratory Quality Manager shall periodically extract and review laboratory-specific feedback entries.
• Data Analysis and Trending: The Chief Medical Technologist / Laboratory Quality Manager shall compile and trend indicator data monthly and quarterly in F-QM-003-A-V0. Data analysis shall be performed at scheduled intervals and immediately whenever data reveals an undesirable trend or variation. Analysis reports shall be presented to the CQI Committee and Management Review.
• Action When Targets Are Not Met: When an indicator falls outside its target or shows adverse trending, the Chief Medical Technologist / Laboratory Quality Manager shall initiate the indicator's Action Plan proportionate to patient-safety risk: - Route acute incidents or nonconformities to Occurrence Management Policy; - Initiate root-cause investigation and CAPA under Corrective and Preventive Action Policy for systemic or recurring failures; - Update risk assessments under Risk Management when new hazards are identified; or - Launch a structured CQI study (F-QM-003-B-V0) for broader process optimization.

5.5 Identification, Prioritization, and Planning of Improvement Opportunities

• Sources of Improvement Opportunities: The laboratory shall systematically identify opportunities for improvement from quality indicator trends, risk assessments (Risk Management), internal audits (Internal Audit), occurrences and CAPAs (Occurrence Management Policy, Corrective and Preventive Action Policy), EQAS results, equipment/LIS reviews, Management Review outputs (Management Review), patient/user/staff feedback, and recognized best practices or innovations.
• Risk-Based Prioritization: Identified opportunities shall be evaluated and prioritized based on their potential impact on examination accuracy, patient and staff safety, regulatory compliance, and resource feasibility. Decisions to select, defer, or decline an identified improvement opportunity, along with the rationale, shall be recorded in F-QM-003-A-V0 or F-QM-003-B-V0.
• Planning and Approval: Planned improvement projects and adoptions of best practices/innovations shall be documented in a CQI Project Charter (F-QM-003-B-V0) defining the objective, scope, risk controls, responsible personnel, timeline, and success criteria. Projects affecting clinical interpretation require Pathologist review; projects requiring hospital-level budget or policy changes require Hospital Director approval prior to implementation.

5.6 Implementation, Feedback, Effectiveness Evaluation, and Institutionalization

• Patient, User, and Personnel Feedback: The laboratory shall actively seek and analyze feedback from patients, clinical users, and laboratory personnel to improve the management system, laboratory operations, and clinical services. Records of feedback and the resulting actions taken shall be maintained, and management shall communicate to personnel the actions taken in response to their feedback.
• Effectiveness Evaluation: Following implementation of an improvement project, the Chief Medical Technologist / Laboratory Quality Manager and CQI Committee shall evaluate its effectiveness against the planned objectives and indicator targets over the defined monitoring duration. If an improvement fails to achieve its target, the plan shall be revised or escalated to CAPA per Corrective and Preventive Action Policy.
• Institutionalization and Organizational Learning: Successful improvements shall be standardized into routine laboratory operations through controlled memoranda, policy/SOP revisions per Document Control Policy, and staff training/competency updates per Orientation Policy and Competency Assessment Policy.
• Periodic Program Review: During the annual Management Review (Management Review), laboratory management shall review all active quality indicators and the Continual Improvement Program to verify their continued appropriateness, retiring or revising obsolete indicators through document control.

6.0 Records

All records generated under this policy, including indicator specifications, monthly/quarterly trend analyses, CQI study schedules, project charters, CQI Committee minutes, and Hospital Director committee designations, shall be controlled in accordance with Control of Records and retained per Laboratory Retention Schedule Policy.

7.0 References

• DOH-Philippines QMS Tool, Section 4 — Monitoring Performance; Section 5 — Quality Improvement Activities
• DOH Administrative Order No. 2021-0037, Annex A — General Guidelines; Annex B1 — Technical Standards for Clinical Laboratories
• ISO 15189:2022, Section 5 — Structural and Governance Requirements; Section 8 — Management System Requirements
• WHO LQMS Handbook, Chapter 15 — Process Improvement

Companion policies:

• Risk Management — risk assessment and risk-based prioritization of improvement opportunities
• Corrective and Preventive Action Policy — root cause analysis and corrective or preventive action when indicators fail targets
• Management Review — executive evaluation of quality indicator trends and CQI study outcomes

Controlled visual annex:

• IG-02 — Quality Indicators at a Glance — one-page visual annex to this policy, controlled under Document Control Policy Section 5.2.6 and registered in F-QM-002-B-V0. Master files: infographics/IG-02-Quality-Indicators-at-a-Glance-LAB-QM-003.png (PNG, print PDF, and editable HTML).